State-of-the-art chemoradiation is no substitution for trimodality approach in the treatment of locally advanced thoracic esophageal squamous cell carcinoma

• Hsin-Yi Yang,
• Kai-Sheng Liao,
• Cheng-Yen Lee,
• Kam-Hong Kam

Affiliations

Hsin-Yi Yang

Clinical Research Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan

Kai-Sheng Liao

Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan; Department of Nursing, Chung-Jen College of Nursing, Health Sciences and Management, Chiayi, Taiwan

Cheng-Yen Lee

Corresponding author.; Department of Radiation Oncology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, No.539, Zhongxiao Rd., East Dist., Chiayi City, 60002, Taiwan; Advanced Manufacturing Systems, National Chung Cheng University, No.168, Sec. 1, University Rd., Min-Hsiung Township, Chia-yi County, 621, Taiwan

Kam-Hong Kam

Corresponding author.; Division of Thoracic Surgery, Department of Surgery, Ditmanson Medical Foundation Chia-Yi Christian Hospital, No.539, Zhongxiao Rd., East Dist., Chiayi City, 60002, Taiwan; Department of Biomedical Sciences, National Chung Cheng University, No.168, Sec. 1, University Rd., Min-Hsiung Township, Chia-yi County, 621, Taiwan